547
Participants
Start Date
January 31, 2013
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
BDP Nasal Aerosol
Placebo
Teva Investigational Site 10522, Hot Springs
Teva Investigational Site 10518, Costa Mesa
Teva Investigational Site 10526, Downey
Teva Investigational Site 10496, Huntington Beach
Teva Investigational Site 10536, Huntington Beach
Teva Investigational Site 10479, Mission Viejo
Teva Investigational Site 10524, Orange
Teva Investigational Site 10508, Paramount
Teva Investigational Site 10495, San Diego
Teva Investigational Site 10504, San Diego
Teva Investigational Site 10505, Stockton
Teva Investigational Site 10514, Centennial
Teva Investigational Site 10503, Colorado Springs
Teva Investigational Site 10499, Lawrenceville
Teva Investigational Site 10474, Savannah
Teva Investigational Site 10490, Stockbridge
Teva Investigational Site 10498, Stockbridge
Teva Investigational Site 10509, DeKalb
Teva Investigational Site 10493, Normal
Teva Investigational Site 10486, Indianapolis
Teva Investigational Site 10494, Louisville
Teva Investigational Site 10515, North Dartmouth
Teva Investigational Site 10540, Traverse City
Teva Investigational Site 10513, Columbia
Teva Investigational Site 10532, Missoula
Teva Investigational Site 10507, Brick
Teva Investigational Site 10534, Corning
Teva Investigational Site 10492, Cortland
Teva Investigational Site 10517, Niagara Falls
Teva Investigational Site 10482, Rochester
Teva Investigational Site 10535, Watertown
Teva Investigational Site 10478, High Point
Teva Investigational Site 10516, Holly Springs
Teva Investigational Site 10485, Canton
Teva Investigational Site 10480, Cincinnati
Teva Investigational Site 10500, Cleveland
Teva Investigational Site 10529, Middleburg Heights
Teva Investigational Site 10537, Ashland
Teva Investigational Site 10527, Medford
Teva Investigational Site 10502, Portland
Teva Investigational Site 10477, Blue Bell
Teva Investigational Site 10484, Upland
Teva Investigational Site 10511, Warwick
Teva Investigational Site 10497, Charleston
Teva Investigational Site 10521, Orangeburg
Teva Investigational Site 10528, Knoxville
Teva Investigational Site 10483, Boerne
Teva Investigational Site 10489, Dallas
Teva Investigational Site 10520, Dallas
Teva Investigational Site 10476, El Paso
Teva Investigational Site 10491, Kerrville
Teva Investigational Site 10487, Plano
Teva Investigational Site 10501, Plano
Teva Investigational Site 10523, San Antonio
Teva Investigational Site 10531, San Antonio
Teva Investigational Site 10539, San Antonio
Teva Investigational Site 10475, Waco
Teva Investigational Site 10488, Salt Lake City
Teva Investigational Site 10506, Salt Lake City
Teva Investigational Site 10510, Salt Lake City
Teva Investigational Site 10519, Burke
Teva Investigational Site 10481, Richmond
Teva Investigational Site 10533, Richmond
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY